Cite
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).
MLA
Elahi, Reza, et al. “An Updated Overview of Recent Advances, Challenges, and Clinical Considerations of IL-6 Signaling Blockade in Severe Coronavirus Disease 2019 (COVID-19).” International Immunopharmacology, vol. 105, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2022.108536.
APA
Elahi, R., Karami, P., Heidary, A. H., & Esmaeilzadeh, A. (2022). An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). International Immunopharmacology, 105, N.PAG. https://doi.org/10.1016/j.intimp.2022.108536
Chicago
Elahi, Reza, Parsa Karami, Amir Hossein Heidary, and Abdolreza Esmaeilzadeh. 2022. “An Updated Overview of Recent Advances, Challenges, and Clinical Considerations of IL-6 Signaling Blockade in Severe Coronavirus Disease 2019 (COVID-19).” International Immunopharmacology 105 (April): N.PAG. doi:10.1016/j.intimp.2022.108536.